Healthcare provider profile · identity verified

Leocadia T Prawdzik, MD

Internal Medicine · HAZLETON, PA · NPI 1346218104

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	400	92
Levothyroxine Sodium	Levothyroxine Sodium	391	81
Eliquis	Apixaban	320	37
Furosemide	Furosemide	281	59
Jardiance	Empagliflozin	243	29
Metoprolol Tartrate	Metoprolol Tartrate	238	45
Amlodipine Besylate	Amlodipine Besylate	228	52
Metoprolol Succinate	Metoprolol Succinate	208	57
Potassium Chloride	Potassium Chloride	197	36
Lisinopril	Lisinopril	180	37
Memantine Hcl	Memantine Hcl	175	28
Torsemide	Torsemide	168	31
Spironolactone	Spironolactone	143	23
Quetiapine Fumarate	Quetiapine Fumarate	139	17
Gabapentin	Gabapentin	132	22
Pantoprazole Sodium	Pantoprazole Sodium	131	30
Sertraline Hcl	Sertraline Hcl	131	26
Valsartan	Valsartan	119	27
Omeprazole	Omeprazole	117	37
Metformin Hcl	Metformin Hcl	114	38
Farxiga	Dapagliflozin Propanediol	107	suppressed
Losartan Potassium	Losartan Potassium	107	33
Donepezil Hcl	Donepezil Hcl	106	14
Clopidogrel	Clopidogrel Bisulfate	104	24
Trazodone Hcl	Trazodone Hcl	92	21
Aripiprazole	Aripiprazole	89	12
Buspirone Hcl	Buspirone Hcl	88	14
Tamsulosin Hcl	Tamsulosin Hcl	88	16
Albuterol Sulfate Hfa	Albuterol Sulfate	85	28
Alprazolam	Alprazolam	83	21
Divalproex Sodium	Divalproex Sodium	79	13
Lactulose	Lactulose	77	suppressed
Allopurinol	Allopurinol	75	17
Duloxetine Hcl	Duloxetine Hcl	73	14
Lorazepam	Lorazepam	72	25
Simvastatin	Simvastatin	72	18
Levetiracetam	Levetiracetam	69	12
Carvedilol	Carvedilol	65	15
Warfarin Sodium	Warfarin Sodium	63	suppressed
Entresto	Sacubitril/Valsartan	62	suppressed
Cephalexin	Cephalexin	60	24
Ondansetron Hcl	Ondansetron Hcl	60	19
Escitalopram Oxalate	Escitalopram Oxalate	59	12
Lamotrigine	Lamotrigine	58	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	56	17
Rybelsus	Semaglutide	54	suppressed
Clonazepam	Clonazepam	53	12
Famotidine	Famotidine	53	17
Benztropine Mesylate	Benztropine Mesylate	52	suppressed
Risperidone	Risperidone	52	12
Tramadol Hcl	Tramadol Hcl	52	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	50	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Paroxetine Hcl	Paroxetine Hcl	46	suppressed
Ezetimibe	Ezetimibe	44	suppressed
Memantine Hcl Er	Memantine Hcl	42	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	41	12
Glimepiride	Glimepiride	39	12
Klor-Con 10	Potassium Chloride	39	suppressed
Ozempic	Semaglutide	39	12
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Vascepa	Icosapent Ethyl	38	suppressed
Bumetanide	Bumetanide	37	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Amiodarone Hcl	Amiodarone Hcl	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Cilostazol	Cilostazol	33	suppressed
Ibuprofen	Ibuprofen	33	11
Lithium Carbonate	Lithium Carbonate	33	suppressed
Theo-24	Theophylline Anhydrous	33	suppressed
Tresiba Flextouch U-200	Insulin Degludec	33	suppressed
Atenolol	Atenolol	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	14
Nuplazid	Pimavanserin Tartrate	29	suppressed
Ondansetron Odt	Ondansetron	29	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Myrbetriq	Mirabegron	27	suppressed
Restasis	Cyclosporine	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Trokendi Xr	Topiramate	26	suppressed
Divalproex Sodium Er	Divalproex Sodium	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Kerendia	Finerenone	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Finasteride	Finasteride	23	suppressed
Wegovy	Semaglutide	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Digoxin	Digoxin	22	suppressed
Naproxen	Naproxen	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Baclofen	Baclofen	21	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	21	suppressed
Icosapent Ethyl	Icosapent Ethyl	21	suppressed
Metolazone	Metolazone	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Prednisone	Prednisone	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Xarelto	Rivaroxaban	21	suppressed
Colesevelam Hcl	Colesevelam Hcl	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Acarbose	Acarbose	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Klor-Con M10	Potassium Chloride	18	suppressed
Mesalamine	Mesalamine	18	suppressed
Mometasone Furoate	Mometasone Furoate	18	11
Valproic Acid	Valproic Acid (As Sodium Salt)	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Azithromycin	Azithromycin	17	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Lumigan	Bimatoprost	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Permethrin	Permethrin	17	suppressed
Secuado	Asenapine	17	suppressed
Glipizide	Glipizide	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	12
Latanoprost	Latanoprost	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Alphagan P	Brimonidine Tartrate	14	suppressed
Amoxicillin	Amoxicillin	14	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Dapagliflozin	Dapagliflozin Propanediol	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Clonidine	Clonidine	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Gemtesa	Vibegron	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	13	suppressed
Asmanex	Mometasone Furoate	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Risperdal Consta	Risperidone Microspheres	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Ingrezza	Valbenazine Tosylate	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error